lefamulin acetate 600mg
Is indicated for the treatment of adults with communityacquired bacterial pneumonia (CABP) caused by the following
susceptible microorganisms: Streptococcus pneumoniae,
Staphylococcus aureus (methicillin-susceptible isolates),
Haemophilus influenzae, Legionella pneumophila, Mycoplasma pneumoniae, and Chlamydophila pneumoniae.